JPMorgan Raises AMX Target to $24.50 but Keeps Neutral—Why the Mispricing Still Exists

The core expectation gap is laid bare in JPMorgan's latest move. The bank raised its price target on America Movil to $24.50 from $23.50 while stubbornly maintaining a "neutral" rating. This is a classic arbitrage setup: the target is up, but the rating is unchanged. The market is being told the stock's fair value has risen, yet it still isn't a buy.

To understand the tension, look at the broader consensus. The average analyst view from 10 analysts is a "Hold" with an average target of $23.40. JPMorgan's new $24.50 target now sits above that average, suggesting the bank sees more upside than the typical analyst. Yet, by keeping "neutral," JPMorgan implies the stock is fairly valued relative to this new, higher target. The stock trades around $23.70, meaning the new target points to a potential upside of about 3.4% from current levels.

The central question, then, is what the market is missing. If the consensus is a "Hold" at $23.40, and JPMorgan's new target is $24.50, why isn't the rating a "Buy"? The answer likely lies in the company's recent performance and the bank's forward-looking estimates. JPMorgan itself noted it upped estimates post the company's Q4 report to reflect stronger Latin America currencies. This suggests the raise is based on improved fundamentals, but perhaps not enough to justify a bullish rating upgrade. The "neutral" stance acts as a brake, signaling that while the outlook has improved, the stock's current price already reflects that improvement. The arbitrage opportunity, therefore, hinges on whether other analysts will eventually follow JPMorgan's lead and raise their targets-or if the stock's recent earnings miss will keep the rating debate stuck in neutral.

The Catalyst: Stronger Latin Currencies and Cash Flow

The raise in JPMorgan's target is anchored in a clear beat on expectations. The bank explicitly cited upped estimates post the company's Q4 report to reflect stronger Latin America currencies. This isn't just a minor tweak; it's a fundamental re-rating of the company's earnings power based on a favorable macro shift. The market had likely priced in a stable currency backdrop, but the actual strength of regional currencies-like a 5.7% decline versus the Chilean peso-provided a meaningful tailwind that JPMorgan is now baking into its models. This currency boost translated directly into operating leverage. Q4 results showed a dramatic jump in profitability, with net profit jumped to MXN 19 billion-about four times the year-ago level. That's a massive beat, driven by EBITDA growing faster than revenue and a significant drop in financing costs. The market consensus, built on prior expectations, may not have fully anticipated this level of profit acceleration. The "neutral" rating, therefore, suggests JPMorgan sees this as a one-time or cyclical benefit from currency, not a structural change in the business model.

The cash flow story reinforces this view. Full-year 2025 free cash flow grew a robust about 40% to MXN 82 billion. This powerful cash generation is the real catalyst for the target increase, as it directly supports the company's debt reduction goals. The net debt/EBITDA ratio fell to 1.52x, which is near management's stated target range of 1.3 to 1.5x. This is a key metric the market watches for financial health and potential shareholder returns. The strong cash flow provides the fuel to hit that target, which in turn reduces financial risk and could support a higher valuation.

The bottom line is that JPMorgan is raising its target because the company delivered a stronger-than-expected financial print, driven by a favorable currency move and exceptional operating leverage. The expectation gap here is that the market may have been focused on subscriber growth or revenue trends, while the real beat came from the bottom line and cash flow. The "neutral" rating, however, acts as a caution: it implies this strength is already priced in, and the stock's path forward now depends on sustaining this profitability and managing the leverage target, not on a repeat of the currency windfall.

The Reality Check: A Missed EPS and a Crowded Street

The market's reaction to the Q4 report tells the real story. Despite a massive beat on net profit and a powerful cash flow print, the stock last quarter missed EPS estimates ($0.35 vs. $0.43). This is the expectation gap in action. The whisper number for earnings was $0.43, and the company came in below that. The market's focus on the bottom line, therefore, was on the beat, but the consensus miss on EPS created a tangible point of disappointment. This sets the stage for a "sell the news" dynamic if future results don't consistently exceed even the lowered bar.

The stock's current price reflects this skepticism. Trading around $23.70, the shares sit just below JPMorgan's new $24.50 target. That narrow gap-about 3.4% upside-indicates the market is not buying the narrative of a major re-rating. It's a classic "priced in" scenario: the positive currency tailwind and cash flow acceleration are already reflected in the share price, leaving little room for error. Any stumble in the next quarter could easily push the stock back toward its average target of $23.40.

Analyst sentiment further underscores the lack of consensus. The street is deeply split, with no clear direction. While JPMorgan raised its target to $24.50 with a "neutral" rating, other banks offer starkly different views. UBS maintains a bullish $30 "Buy" rating, while Bank of America has a $26 "Neutral" target. This crowded, conflicting street view shows no unified belief in the stock's trajectory. It suggests the positive metrics are being interpreted through different lenses-some see a currency-driven profit spike, others see a sustainable operational turnaround. In such a divided environment, the stock is vulnerable to a guidance reset if the next earnings report fails to match the heightened expectations set by the Q4 beat.

The bottom line is that the easy money from the currency tailwind may be made. The stock's neutral rating and tight price range suggest the market is waiting for more proof that the company can deliver consistent, top-line growth to justify a higher valuation. For now, the expectation gap is not in the upside target, but in the stock's ability to meet the lowered EPS consensus and move decisively higher.

Catalysts and Risks: What to Watch for the Next Move

The expectation gap will be resolved by the next set of forward-looking signals. The market is now waiting to see if the company can translate its strong Q4 performance into a credible plan for 2026. Three key metrics will determine whether the stock moves decisively higher or gets stuck in neutral.

First, watch the company's capital expenditure guidance. Management has set 2026 CapEx at about 14–15% of revenues (~$6.8–7.0 billion). This is a critical test of financial discipline. The guidance must align with the company's powerful cash flow growth. Full-year 2025 free cash flow surged about 40% to MXN 82 billion. If the planned spending is too aggressive relative to that cash generation, it could pressure the net debt/EBITDA ratio and force a reassessment of the leverage target. The market will be looking for a CapEx plan that supports growth without straining the balance sheet.

Second, monitor Latin American currency performance. JPMorgan's optimism is directly tied to the weakening U.S. dollar against practically all the currencies in the region. This tailwind drove the massive profit beat. The expectation gap hinges on whether this macro environment persists. If the dollar strengthens again, it could quickly reverse the currency benefit and pressure earnings. The stock's path will be closely linked to the stability of these exchange rates.

Finally, the next major catalyst is the company's full-year 2026 guidance. This will reset expectations for the year. After the Q4 report, the market is focused on the next earnings print. If management provides guidance that exceeds the lowered EPS consensus, it could close the expectation gap and justify a rating upgrade. If the outlook is cautious or fails to match the momentum of the previous quarter, it could widen the gap and trigger a sell-off. The crowded, conflicting analyst views show the market is waiting for this clarity.